The impact of COVID-19 on medication reviews in English primary care. An OpenSAFELY-TPP analysis of 20 million adult electronic health records.
Journal article
OpenSAFELY Collaborative None. et al, (2024), Br J Clin Pharmacol
OpenSAFELY: Measuring BMI in 22 million patients in England
Journal article
Park RY. et al, (2024), Wellcome Open Research, 9, 26 - 26
OpenSAFELY: a platform for analysing electronic health records designed for reproducible research
Preprint
Nab L. et al, (2024)
Weight trends amongst adults with diabetes or hypertension during the COVID-19 pandemic: an observational study using OpenSAFELY.
Journal article
Samuel M. et al, (2024), Br J Gen Pract
CHALLENGES IN ESTIMATING THE EFFECTIVENESS OF 2 DOSES OF COVID-19 VACCINE BEYOND 6 MONTHS IN ENGLAND
Journal article
Horne EMF. et al, (2024), American Journal of Epidemiology, 193, 227 - 231
Implementing Germ Defence digital behaviour change intervention via all primary care practices in England to reduce respiratory infections during the COVID-19 pandemic: an efficient cluster randomised controlled trial using the OpenSAFELY platform
Journal article
Ainsworth B. et al, (2023), Implementation science : IS, 18
Clinical and health inequality risk factors for non-COVID-related sepsis during the global COVID-19 pandemic: a national case-control and cohort study
Journal article
Zhong X. et al, (2023), eClinicalMedicine, 66
Comparative effectiveness of sotrovimab and molnupiravir for preventing severe COVID-19 outcomes in patients on kidney replacement therapy: observational study using the OpenSAFELY-UKRR and SRR databases
Journal article
Zheng B. et al, (2023), Clinical Kidney Journal, 16, 2048 - 2058
Impact of the COVID-19 pandemic on antipsychotic prescribing in individuals with autism, dementia, learning disability, serious mental illness or living in a care home: A federated analysis of 59 million patients' primary care records in situ using OpenSAFELY
Journal article
Macdonald O. et al, (2023), BMJ Health and Care Informatics, 26
Anaphylaxis events following COVID-19 antiviral and neutralising monoclonal antibody treatment for non-hospitalised patients: data from the OpenSAFELY-TPP platform
Journal article
Zheng B. et al, (2023), Wellcome Open Research, 8, 387 - 387
Healthcare in England was affected by the COVID-19 pandemic across the pancreatic cancer pathway: A cohort study using OpenSAFELY-TPP
Journal article
Lemanska A. et al, (2023), eLife, 12
Comparative effectiveness of two- and three-dose COVID-19 vaccination schedules involving AZD1222 and BNT162b2 in people with kidney disease: a linked OpenSAFELY and UK Renal Registry cohort study
Journal article
Parker EPK. et al, (2023), The Lancet Regional Health - Europe, 30
Ethnic differences in the indirect effects of the COVID-19 pandemic on clinical monitoring and hospitalisations for non-COVID conditions in England: a population-based, observational cohort study using the OpenSAFELY platform
Journal article
Costello RE. et al, (2023), eClinicalMedicine, 61
Challenges in Estimating the Effectiveness of COVID-19 Vaccination Using Observational Data
Journal article
Hulme WJ. et al, (2023), Annals of internal medicine, 176, 685 - 693
Changes in COVID-19-related mortality across key demographic and clinical subgroups in England from 2020 to 2022: a retrospective cohort study using the OpenSAFELY platform
Journal article
Nab L. et al, (2023), The Lancet Public Health, 8, e364 - e377
Changes in medication safety indicators in England throughout the covid-19 pandemic using OpenSAFELY: population based, retrospective cohort study of 57 million patients using federated analytics
Journal article
Fisher L. et al, (2023), BMJ Medicine, 2, e000392 - e000392
Comparative effectiveness of BNT162b2 versus mRNA-1273 covid-19 vaccine boosting in England: matched cohort study in OpenSAFELY-TPP
Journal article
Hulme WJ. et al, (2023), BMJ (Clinical research ed.), 380